Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04272034
Title	Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors
Recruitment	Terminated
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	Incyte Corporation
Indications	Advanced Solid Tumor
Therapies	INCB099318
Age Groups:	senior \| adult
Covered Countries	USA \| SWE \| NOR \| GBR \| FIN \| DNK \| BEL